AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSN272200800049CALTIMMUNE, INC.
Overview
Award facts
- Net obligations
- $962.25K
- $962,249of $962.25K potential value
- Period of performance
- Aug 6, 2013 to Aug 6, 2013
- Ended
- Modifications
- 3
- Latest action Aug 6, 2013
- Contract type
- Definitive contract
- PIID HHSN272200800049C
Description of requirement
BIODEFENSE VACCINE ENHANCEMENT
Dates and value
- Award date
- Signed on Sep 25, 2008
- Potential end of performance
- Aug 5, 2013
- Current value
- $962,249Base and exercised options
- Potential value (if all options are exercised)
- $962,249
Obligations by fiscal year of action
- FY2013: -$2,937,751 (de-obligation)
- FY2010: -$6,100,000 (de-obligation)
- FY2008: $10,000,000
Total across 3 fiscal years: $962,249
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 6, 2013. View on USAspending · Recipient on SAM.gov
Recipient
NameALTIMMUNE, INC.
LocationANNAPOLIS, MD
UEIHCX2XDMYTA35
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyALTIMMUNE, INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NIH, NIAID DEA OA OFC ACQUISITIONS
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NIH, NIAID DEA OA OFC ACQUISITIONS
Place of performance
- Place of performance
- Annapolis, Anne Arundel County, Maryland 21401-7378
- Congressional district (place of performance)
- MD-03As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN13R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Basic researchBR
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 13
Solicitation and notices
- Solicitation ID
- BAA AI2007007(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Biodefense vaccine enhancement
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- Other undefinitized actionB
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 25, 2008Base obligation at award: $10,000,000
- Latest action
- Aug 6, 2013 — Funding onlyModification 3; obligation change -$2,937,751; funding only: changes obligations, not scope
- Latest funding action
- Aug 6, 2013 — Funding onlyModification 3; obligation change -$2,937,751; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action2
- Funding only1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- Yes
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$2,937,751
- Latest action: change in base and all options
- -$2,937,751
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- Yes
- Walsh-Healey Act (materials and supplies)
- Yes
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United kingdomGBR
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- IT commercial item category
- Not IT products or servicesZ
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 00272
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 00272